Koers ViaDerma, Inc. Other OTC
Aandelen
VDRM
US92555K1016
Biotechnologie & Medisch Onderzoek
Omzet 2015 | 192K 177K | Omzet 2016 | 252K 232K | Marktkapitalisatie | 618K 570K |
---|---|---|---|---|---|
Nettowinst (verlies) 2015 | - 0 | Nettowinst (verlies) 2016 | - 0 | EV/omzet 2015 | 1,5 x |
Nettoschuld 2015 | 288K 266K | Nettoschuld 2016 | 297K 274K | EV/omzet 2016 | 3,63 x |
K/w-verhouding 2015 |
10,7
x | K/w-verhouding 2016 |
-3,3
x | Werknemers | - |
Dividendrendement 2015 * |
-
| Dividendrendement 2016 |
-
| Vrij verhandelbaar | 99% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chris Ayo Otiko
CEO | Chief Executive Officer | - | 31-03-14 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chris Ayo Otiko
CEO | Chief Executive Officer | - | 31-03-14 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+54,05% | 63,85 mld. | |
-2,02% | 41,83 mld. | |
+40,01% | 40,47 mld. | |
-10,22% | 27,17 mld. | |
+13,42% | 26,52 mld. | |
-21,60% | 18,69 mld. | |
+2,89% | 12,73 mld. | |
+22,40% | 12,11 mld. | |
+27,49% | 12,07 mld. |